Helix Biotech is a CDMO specializing in LNPs, liposomes, and hybrid nanoparticles. Headquartered in Knoxville, Tennessee, Helix brings decades of experience in GMP manufacturing, formulation, engineering, and process design to their clients’ projects. The company provides both preclinical and clinical stage development, manufacturing, and analytical services to emerging biotechs and established pharmaceutical companies that are developing nucleic acid, small molecule, and protein therapeutics.